Cargando…

Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study

BACKGROUND: Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Yun, Li, Linghua, He, Xiang, Hu, Fengyu, Deng, Xizi, Cai, Weiping, Li, Junbin, Ling, Xuemei, Fan, Qinghong, Cai, Xiaoli, Li, Liya, Li, Feng, Tang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422730/
https://www.ncbi.nlm.nih.gov/pubmed/34488793
http://dx.doi.org/10.1186/s12985-021-01653-6
_version_ 1783749334369566720
author Lan, Yun
Li, Linghua
He, Xiang
Hu, Fengyu
Deng, Xizi
Cai, Weiping
Li, Junbin
Ling, Xuemei
Fan, Qinghong
Cai, Xiaoli
Li, Liya
Li, Feng
Tang, Xiaoping
author_facet Lan, Yun
Li, Linghua
He, Xiang
Hu, Fengyu
Deng, Xizi
Cai, Weiping
Li, Junbin
Ling, Xuemei
Fan, Qinghong
Cai, Xiaoli
Li, Liya
Li, Feng
Tang, Xiaoping
author_sort Lan, Yun
collection PubMed
description BACKGROUND: Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comprehensively analyze the prevalence of TDR and the transmission clusters of HIV-1 infected persons before ART in Guangdong. METHODS: The HIV-1 treatment-naïve patients were recruited between January 2018 and December 2018. The HIV-1 pol region was amplified by reverse transcriptional PCR and sequenced by sanger sequencing. Genotypes, surveillance drug resistance mutations (SDRMs) and TDR were analyzed. Genetic transmission clusters among patients were identified by pairwise Tamura-Nei 93 genetic distance, with a threshold of 0.015. RESULTS: A total of 2368 (97.17%) HIV-1 pol sequences were successfully amplified and sequenced from the enrolled 2437 patients. CRF07_BC (35.90%, 850/2368), CRF01_AE (35.56%, 842/2368) and CRF55_01B (10.30%, 244/2368) were the main HIV-1 genotypes circulating in Guangdong. Twenty-one SDRMs were identified among fifty-two drug-resistant sequences. The overall prevalence of TDR was 2.20% (52/2368). Among the 2368 patients who underwent sequencing, 8 (0.34%) had TDR to protease inhibitors (PIs), 22 (0.93%) to nucleoside reverse transcriptase inhibitors (NRTIs), and 23 (0.97%) to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two (0.08%) sequences showed dual-class resistance to both NRTIs and NNRTIs, and no sequences showed triple-class resistance. A total of 1066 (45.02%) sequences were segregated into 194 clusters, ranging from 2 to 414 sequences. In total, 15 (28.85%) of patients with TDR were included in 9 clusters; one cluster contained two TDR sequences with the K103N mutation was observed. CONCLUSIONS: There is high HIV-1 genetic heterogeneity among patients in Guangdong. Although the overall prevalence of TDR is low, it is still necessary to remain vigilant regarding some important SDRMs.
format Online
Article
Text
id pubmed-8422730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84227302021-09-09 Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study Lan, Yun Li, Linghua He, Xiang Hu, Fengyu Deng, Xizi Cai, Weiping Li, Junbin Ling, Xuemei Fan, Qinghong Cai, Xiaoli Li, Liya Li, Feng Tang, Xiaoping Virol J Research BACKGROUND: Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comprehensively analyze the prevalence of TDR and the transmission clusters of HIV-1 infected persons before ART in Guangdong. METHODS: The HIV-1 treatment-naïve patients were recruited between January 2018 and December 2018. The HIV-1 pol region was amplified by reverse transcriptional PCR and sequenced by sanger sequencing. Genotypes, surveillance drug resistance mutations (SDRMs) and TDR were analyzed. Genetic transmission clusters among patients were identified by pairwise Tamura-Nei 93 genetic distance, with a threshold of 0.015. RESULTS: A total of 2368 (97.17%) HIV-1 pol sequences were successfully amplified and sequenced from the enrolled 2437 patients. CRF07_BC (35.90%, 850/2368), CRF01_AE (35.56%, 842/2368) and CRF55_01B (10.30%, 244/2368) were the main HIV-1 genotypes circulating in Guangdong. Twenty-one SDRMs were identified among fifty-two drug-resistant sequences. The overall prevalence of TDR was 2.20% (52/2368). Among the 2368 patients who underwent sequencing, 8 (0.34%) had TDR to protease inhibitors (PIs), 22 (0.93%) to nucleoside reverse transcriptase inhibitors (NRTIs), and 23 (0.97%) to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two (0.08%) sequences showed dual-class resistance to both NRTIs and NNRTIs, and no sequences showed triple-class resistance. A total of 1066 (45.02%) sequences were segregated into 194 clusters, ranging from 2 to 414 sequences. In total, 15 (28.85%) of patients with TDR were included in 9 clusters; one cluster contained two TDR sequences with the K103N mutation was observed. CONCLUSIONS: There is high HIV-1 genetic heterogeneity among patients in Guangdong. Although the overall prevalence of TDR is low, it is still necessary to remain vigilant regarding some important SDRMs. BioMed Central 2021-09-06 /pmc/articles/PMC8422730/ /pubmed/34488793 http://dx.doi.org/10.1186/s12985-021-01653-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lan, Yun
Li, Linghua
He, Xiang
Hu, Fengyu
Deng, Xizi
Cai, Weiping
Li, Junbin
Ling, Xuemei
Fan, Qinghong
Cai, Xiaoli
Li, Liya
Li, Feng
Tang, Xiaoping
Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_full Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_fullStr Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_full_unstemmed Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_short Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
title_sort transmitted drug resistance and transmission clusters among hiv-1 treatment-naïve patients in guangdong, china: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422730/
https://www.ncbi.nlm.nih.gov/pubmed/34488793
http://dx.doi.org/10.1186/s12985-021-01653-6
work_keys_str_mv AT lanyun transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT lilinghua transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT hexiang transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT hufengyu transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT dengxizi transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT caiweiping transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT lijunbin transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT lingxuemei transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT fanqinghong transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT caixiaoli transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT liliya transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT lifeng transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy
AT tangxiaoping transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy